Web1 feb. 1998 · A summary of the hematologic toxicity observed at the recommended phase II doses in the three phase I studies that evaluated a daily-times-five-day schedule of topotecan is presented in Table 1. In these studies, both minimally and extensively pretreated patients were evaluated. Web10 jun. 2016 · Hematologic toxicity of grade III/IV in the OW group was 52.4 versus 32.3 % in the NW group (OR = 2.31, 95 % CI 0.74 to 7.3; p = 0.15): thrombocytopenia 42.9 versus 12.9 % (OR = 5.06, 95 % CI 1.30 to 19.72; p < 0.02); neutropenia 38.1 versus 29.0 % (OR = 1.50, 95 % CI 0.47 to 4.86; p = 0.49); anemia 28.6 versus 9.7 % (OR =3.73, 95 % CI …
Hematotoxicity definition of Hematotoxicity by Medical dictionary
Webblood toxicity血液毒性 1.Investigation of blood toxicity in association with topotecan;拓扑替康血液毒性反应的观察与研究 3)Haematotoxicity血液毒性 1.Objective: Study on the … WebHematologic toxicity observed in the pediatric population was higher than that seen in the adult population [see Dosage and Administration (2.1), Adverse Reactions (6.1), Clinical Studies (14.2)]. Nervous system adverse reactions have been reported for 42% of pediatric patients across the Phase I and Phase II trials. shoreline police department online report
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
Web4 jun. 2024 · Twenty-three patients experienced grade III or IV toxicity, and common were diarrhea (13), vomiting (12), and anemia (7). CONCLUSION First-line modified flourouracil, oxaliplatin, and irinotecan is feasible in unresectable GBC with encouraging responses. Toxicities are higher but manageable. WebViele übersetzte Beispielsätze mit "hematologic toxicity" – Deutsch-Englisch Wörterbuch und Suchmaschine für Millionen von Deutsch-Übersetzungen. WebCTC Version 2.0 Publish Date: April 30, 1999 Cancer Therapy Evaluation Program 4 Revised March 23, 1998 Common Toxicity Criteria, Version 2.0 DCTD, NCI, NIH, DHHS … sandringham weston super mare